Antibody-Negative Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS) in a Patient with Follicular Lymphoma Accompanied by an Excess of Peripheral Blood CD8+ Lymphocytes.
autoantibodies
autoimmune blistering diseases
cancer
cytotoxic lymphocytes
paraneoplastic pemphigus
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
28 03 2022
28 03 2022
Historique:
received:
15
01
2022
revised:
10
03
2022
accepted:
21
03
2022
entrez:
21
4
2022
pubmed:
22
4
2022
medline:
26
4
2022
Statut:
epublish
Résumé
Paraneoplastic autoimmune multiorgan syndrome (PAMS) is a life-threatening autoimmune disease associated with malignancies. Here, we present a patient initially misdiagnosed with "chronic" Stevens-Johnson syndrome. Over a year later, the patient was diagnosed with stage IV follicular lymphoma and treated with an anti-CD20 antibody. At this time, his skin condition had significantly worsened, with erythroderma and massive mucosal involvement, including in the mouth, nose, eyes, and genital region. Histopathology revealed lichenoid infiltrates with interface dermatitis, dyskeratoses, necrotic keratinocytes, and a dense CD8+ infiltrate with strong epidermotropism. Direct and indirect immunofluorescence tests for autoantibodies were negative. Remarkably, we retrospectively discovered a chronic increase in peripheral CD8+ lymphocytes, persisting for over a year. Consequently, the patient was diagnosed with antibody-negative PAMS. Three weeks later, he succumbed to respiratory failure. This dramatic case highlights the challenges in diagnosing PAMS, particularly in cases where immunofluorescence assays are negative. Importantly, we observed, for the first time, a chronic excess of CD8+ peripheral blood lymphocytes, associated with PAMS, consistent with the systemic, autoreactive T-cell-driven processes that characterize this condition.
Identifiants
pubmed: 35448168
pii: curroncol29040194
doi: 10.3390/curroncol29040194
pmc: PMC9032549
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
2395-2405Références
Dermatol Online J. 2018 Feb 15;24(2):
pubmed: 29630151
J Comput Assist Tomogr. 2006 Jan-Feb;30(1):92-4
pubmed: 16365580
J Cutan Pathol. 2021 Sep;48(9):1133-1138
pubmed: 33719070
Lung. 2020 Feb;198(1):157-161
pubmed: 31807920
Int J Clin Exp Pathol. 2020 Jul 01;13(7):1915-1923
pubmed: 32782723
J Korean Med Sci. 2010 May;25(5):658-62
pubmed: 20436698
N Engl J Med. 1990 Dec 20;323(25):1729-35
pubmed: 2247105
J Am Acad Dermatol. 2007 Jan;56(1):153-9
pubmed: 17097371
Br J Dermatol. 2019 May;180(5):1238-1239
pubmed: 30648258
Curr Probl Cancer. 2022 Apr;46(2):100813
pubmed: 34844771
Cureus. 2020 Jul 26;12(7):e9405
pubmed: 32864234
Arch Dermatol. 2001 Feb;137(2):193-206
pubmed: 11176692
Autoimmun Rev. 2018 Oct;17(10):1002-1010
pubmed: 30103046
Am J Respir Cell Mol Biol. 2006 Jan;34(1):108-18
pubmed: 16195540
N Engl J Med. 2003 Jul 24;349(4):407-8
pubmed: 12878753
Br J Haematol. 2010 May;149(4):464
pubmed: 20180798
J Immunol. 2013 Jul 1;191(1):83-90
pubmed: 23729442
Ann Hematol. 2018 Mar;97(3):543-544
pubmed: 29143865
Ital J Dermatol Venerol. 2021 Apr;156(2):174-183
pubmed: 33070576
J Clin Exp Hematop. 2015;55(2):83-8
pubmed: 26490520
Case Rep Pathol. 2020 Jun 17;2020:7350759
pubmed: 32685228
Acta Haematol. 2014;132(1):73-4
pubmed: 24481059
Ann Hematol. 2001 Jul;80(7):430-5
pubmed: 11529471
Front Immunol. 2019 Jun 04;10:1259
pubmed: 31214197
Clin Exp Dermatol. 2018 Jul;43(5):613-615
pubmed: 29761536
J Dermatol. 2007 Oct;34(10):734-5
pubmed: 17908152
Transplantation. 2017 Oct;101(10):2469-2476
pubmed: 28926522
Acta Derm Venereol. 2020 Jul 2;100(14):adv00204
pubmed: 32516424
Mediators Inflamm. 2013;2013:764290
pubmed: 24347833